Test bank for pharmacotherapeutics for advanced practice- a practical approach
5th edition arcangelo ultimate guide newest version 2024-25.
Test Bank: Pharmacotherapeutics for Advanced Practice: A Practical Approach,
5th Edition (Arcangelo)
180 Practice Questions with Answers and Rationales
Chapter 1: Issues for the Practitioner in Drug Therapy
1. Nurse practitioner prescriptive authority is regulated by:
A. The National Council of State Boards of Nursing
B. The U.S. Drug Enforcement Administration
C. The State Board of Nursing for each state
D. The State Board of Pharmacy
Answer: C
Rationale: Prescriptive authority for nurse practitioners is regulated at the state
level by each state's Board of Nursing. State laws and regulations determine the
scope of NP practice, including prescriptive authority, rather than national
organizations or federal agencies. The DEA regulates controlled substance
scheduling and registration but does not establish prescriptive authority.
,2. Physician Assistant (PA) prescriptive authority is regulated by:
A. The National Council of State Boards of Nursing
B. The U.S. Drug Enforcement Administration
C. The State Board of Nursing
D. The State Board of Medical Examiners
Answer: D
Rationale: PA prescriptive authority is regulated by the State Board of Medical
Examiners because PAs practice under the supervision of physicians. This differs
from NPs, whose authority is regulated by nursing boards.
3. Clinical judgment in prescribing includes:
A. Factoring in the cost to the patient of the medication prescribed
B. Always prescribing the newest medication available for the disease process
C. Handing out drug samples to poor patients
D. Prescribing all generic medications to cut costs
,Answer: A
Rationale: Clinical judgment in prescribing requires considering multiple factors
including cost to the patient, efficacy, safety, and patient-specific variables. Cost is
an important consideration for adherence and should be part of prescribing
decisions. Prescribing the newest medication is not always appropriate, and while
generics are often preferred, they are not appropriate for all situations.
4. Criteria for choosing an effective drug for a disorder include:
A. Asking the patient what drug they think would work best for them
B. Consulting nationally recognized guidelines for disease management
C. Prescribing medications that are available as samples before writing a
prescription
D. Following U.S. Drug Enforcement Administration (DEA) guidelines for
prescribing
Answer: B
Rationale: Evidence-based practice requires consulting nationally recognized
guidelines for disease management when selecting pharmacotherapy. These
, guidelines synthesize current research and provide recommendations for optimal
treatment. Patient preferences should be considered, but clinical guidelines
provide the foundation for appropriate drug selection.
5. Nurse practitioner practice may thrive under health-care reform due to:
A. The demonstrated ability of nurse practitioners to control costs and improve
patient outcomes
B. The fact that nurse practitioners will be able to practice independently
C. The fact that nurse practitioners will have full reimbursement under health-
care reform
D. The ability to shift accountability for Medicaid to the state level
Answer: A
Rationale: Research has demonstrated that NPs provide cost-effective, high-
quality care with improved patient outcomes. This evidence supports the
expanded role of NPs in healthcare reform initiatives. Cost control and outcome
improvement are key drivers for NP practice growth.
6. Pharmacotherapeutics is defined as:
5th edition arcangelo ultimate guide newest version 2024-25.
Test Bank: Pharmacotherapeutics for Advanced Practice: A Practical Approach,
5th Edition (Arcangelo)
180 Practice Questions with Answers and Rationales
Chapter 1: Issues for the Practitioner in Drug Therapy
1. Nurse practitioner prescriptive authority is regulated by:
A. The National Council of State Boards of Nursing
B. The U.S. Drug Enforcement Administration
C. The State Board of Nursing for each state
D. The State Board of Pharmacy
Answer: C
Rationale: Prescriptive authority for nurse practitioners is regulated at the state
level by each state's Board of Nursing. State laws and regulations determine the
scope of NP practice, including prescriptive authority, rather than national
organizations or federal agencies. The DEA regulates controlled substance
scheduling and registration but does not establish prescriptive authority.
,2. Physician Assistant (PA) prescriptive authority is regulated by:
A. The National Council of State Boards of Nursing
B. The U.S. Drug Enforcement Administration
C. The State Board of Nursing
D. The State Board of Medical Examiners
Answer: D
Rationale: PA prescriptive authority is regulated by the State Board of Medical
Examiners because PAs practice under the supervision of physicians. This differs
from NPs, whose authority is regulated by nursing boards.
3. Clinical judgment in prescribing includes:
A. Factoring in the cost to the patient of the medication prescribed
B. Always prescribing the newest medication available for the disease process
C. Handing out drug samples to poor patients
D. Prescribing all generic medications to cut costs
,Answer: A
Rationale: Clinical judgment in prescribing requires considering multiple factors
including cost to the patient, efficacy, safety, and patient-specific variables. Cost is
an important consideration for adherence and should be part of prescribing
decisions. Prescribing the newest medication is not always appropriate, and while
generics are often preferred, they are not appropriate for all situations.
4. Criteria for choosing an effective drug for a disorder include:
A. Asking the patient what drug they think would work best for them
B. Consulting nationally recognized guidelines for disease management
C. Prescribing medications that are available as samples before writing a
prescription
D. Following U.S. Drug Enforcement Administration (DEA) guidelines for
prescribing
Answer: B
Rationale: Evidence-based practice requires consulting nationally recognized
guidelines for disease management when selecting pharmacotherapy. These
, guidelines synthesize current research and provide recommendations for optimal
treatment. Patient preferences should be considered, but clinical guidelines
provide the foundation for appropriate drug selection.
5. Nurse practitioner practice may thrive under health-care reform due to:
A. The demonstrated ability of nurse practitioners to control costs and improve
patient outcomes
B. The fact that nurse practitioners will be able to practice independently
C. The fact that nurse practitioners will have full reimbursement under health-
care reform
D. The ability to shift accountability for Medicaid to the state level
Answer: A
Rationale: Research has demonstrated that NPs provide cost-effective, high-
quality care with improved patient outcomes. This evidence supports the
expanded role of NPs in healthcare reform initiatives. Cost control and outcome
improvement are key drivers for NP practice growth.
6. Pharmacotherapeutics is defined as:
